Filter Results :

Your search for therapies returned 63 reports

Sort by


Therapies for Resistant and Recurrent Metastatic Cancer

06 Nov 2017  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022.Report Includes-84 data tables and 46 additional tables-An overview of the market for the resistant and recurrent metastatic cancer, ...

$ 4,950.00

Read More

eTheRNA Immunotherapies NV - Pharmaceuticals & Healthcare - Deals and Alliances Profile

12 Oct 2017  |  Published by:  GlobalData
SummaryeTheRNA Immunotherapies NV (eTheRNA) focuses on the development of novel immunotherapies for the treatment of cancers and infectious diseases. Its pipeline portfolio includes mRNA-based immunotherapies for various indications such as melanoma, triple negative breast cancer and infectious dise...

$ 250.00

Read More

BioRestorative Therapies Inc (BRTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

11 Oct 2017  |  Published by:  GlobalData
SummaryBioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment ...

$ 250.00

Read More

Advanced Inhalation Therapies (AIT) Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

11 Oct 2017  |  Published by:  GlobalData
SummaryAdvanced Inhalation Therapies (AIT) Ltd (AIT), formerly KokiCare Inc is a provider of chronic disease management solutions. The company develops products for bronchiolttis, MABSC, chronic obstructive pulmonary disease, diabetic foot ulcers, stroke and cystic fibrosis. It develops proprietary ...

$ 250.00

Read More

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report and Forecast to 2021

09 Oct 2017  |  Published by:  9Dimen Research
Autologous Stem Cell and Non-Stem Cell Based Therapies Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) a...

$ 1,990.00

Read More

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size and Forecast to 2021

09 Oct 2017  |  Published by:  9Dimen Research
Autologous Stem Cell and Non-Stem Cell Based Therapies Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) a...

$ 3,200.00

Read More

Frontier Pharma: Ophthalmology Therapeutics - Gene Therapies and First-in-Class Targets Offer Novel Treatments for Substantial Unmet Needs in a Pipeline Dominated by Angiogenic and Immune Signaling Drugs

01 Oct 2017  |  Published by:  GBI Research
SummaryThe ophthalmologic therapy area encompasses a wide range of disorders affecting the eye and its supporting structures. These include glaucoma, age-related macular degeneration (AMD), diabetic retinopathy (DR), diabetic macular edema (DME) and dry eye syndrome (DES). The therapy area is charac...

$ 6,995.00

Read More

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

01 Oct 2017  |  Published by:  GBI Research
SummaryDiabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination of these. Chronic hyperglycemia is associated with the long-term damage, dysfunction and fai...

$ 4,995.00

Read More

Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers

01 Sep 2017  |  Published by:  GBI Research
SummaryThe respiratory therapy area consists of indications that affect the respiratory system in different ways, such as inflammation, the scarring of lung tissue and excessive production of mucus in the airways. This report focuses on the key therapy area indications of asthma, chronic obstructive...

$ 4,995.00

Read More

Frontier Pharma: Cancer Immunotherapies - First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets

01 Sep 2017  |  Published by:  GBI Research
SummaryCancer is a group of diseases that are defined by abnormal cell growth, local tissue invasion and eventual migration to other parts of the body. The diseases are driven by the accumulation of genetic mutations, which provide selective advantages to cells allowing them to evolve and propagate ...

$ 6,995.00

Read More

Global Personalized Cell Therapies Market: - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

01 Sep 2017  |  Published by:  Precision Business Insights
Global Personalized Cell Therapies Market: By Cell Type (Hematopoietic Stem Cell, Skeletal Muscle Stem Cell, Mesenchymal Stem Cells, Lymphocytes, Others), By Application (Cardiovascular Disorders, Diabetes, Neurological Disorders, Cancer, Others), and Geography - Market Estimation, Dynamics, Regiona...

$ 4,400.00

Read More

Vital Therapies Inc (VTL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

28 Aug 2017  |  Published by:  GlobalData
SummaryVital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute li...

$ 250.00

Read More

Intra-Cellular Therapies Inc (ITCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 Aug 2017  |  Published by:  GlobalData
SummaryIntra-Cellular Therapies Inc (ITI) is a biopharmaceutical company that discovers and develops novel drugs for the treatment of neuropsychiatric and neurologic disorders. The company's lead product candidate include ITI-007-lumateperone, which is intended for the treatment of schizophrenia, be...

$ 250.00

Read More

Diabetic Nephropathy Market (By Mode of Treatment: Drug Modifying Therapies, and Others; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

11 Aug 2017  |  Published by:  Variant Market Research
Global Diabetic Nephropathy Market is estimated to reach $3,826 million by 2024; growing at a CAGR of 5.9% from 2016 to 2024. Diabetic nephropathy involves damage of kidney due to the presence of diabetic mellitus. It is a progressive kidney disease majorly caused due to occurrence if persistent pro...

$ 4,995.00

Read More

Vital Therapies Inc (VTL) - Financial and Strategic SWOT Analysis Review

07 Aug 2017  |  Published by:  GlobalData
SummaryVital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute li...

$ 300.00

Read More
Total 63 records.